The effect of drug treatment on functional outcomes of hip and knee joint replacement in patients with rheumatoid arthritis




hip replacement arthroplasty, knee placement arthroplasty, rheumatoid arthritis


Aim – to determine the effect of drug antirheumatic therapy on the functional outcomes of hip and knee arthroplasty in patients with rheumatoid arthritis.

Materials and methods. The results of 160 operations of total hip arthroplasty and 148 operations of total arthroplasty of knee joints in patients with rheumatoid joint lesions were analyzed using mathematical methods of statistical processing. Patients were divided into 4 groups: Group I – without anti-inflammatory therapy, Group II – received hormone therapy, Group III – basic therapy and Group IV – received both the basic and hormonal therapy at the time of surgery.

Results. The obtained results indicated a moderate correlation between therapy and the joint range of motion of the lower extremities using basic therapy and combined nonsteroidal, hormonal and basic therapy, and the range of motion differed significantly in combination therapy from hormonal alone. The highest scores of the J. Joseph, E. E. Kaufman rating scale were observed in combination therapy with NSAIDs, hormonal and basic therapy; the lower scores – in hormonal and NSAIDs combination; and the lowest ones – in the combination of basic therapy with NSAIDs. The greatest increase in the knee joint range of motion was observed in the patients who received hormonal drugs or basic therapy compared to the patients who did not take any one or received both of these medicines in combination. Almost the same effect of antirheumatic therapy on the results of both hip and knee arthroplasty was determined with an upward trend in percentage of good and excellent results in males regardless of the lesion location and the most optimal ratio between satisfactory-unsatisfactory and good-excellent results in the patients under 40 years of age.

Conclusions. The studies conducted allow to consider the combined drug therapy as a factor of weak and moderate influence on the functional outcomes of hip and knee arthroplasty in the late stages of rheumatoid arthritis and suggest that antirheumatic drug therapy should not be discontinued in the perioperative period.


Gerasymenko, S. I., Poluliakh, M. V., Babko, A. M., & Gerasymenko, A. S. (2019). Vplyv suputnikh faktoriv zakhvoriuvannia ta konservatyvnoho likuvannia na rezultaty totalnoho endoprotezuvannia kulshovoho suhloba u khvorykh na revmatoidnyi artryt [Influence of concomitant factors of disease and conservative treatment on the results of total hip arthroplasty in patients with rheumatoid arthritis]. Ukrainskyi revmatolohichnyi zhurnal, (4), 68-75. [in Ukrainian].

Burn, E., Edwards, C. J., Murray, D. W., Silman, A., Cooper, C., Arden, N. K., Pinedo-Villanueva, R., & Prieto-Alhambra, D. (2019). The effect of rheumatoid arthritis on patient-reported outcomes following knee and hip replacement: evidence from routinely collected data. Rheumatology, 58(6), 1016-1024.

Peña, M., Quirós-Donate, J., Pérez Fernández, E., Crespí-Villarías, N., Dieguez Costa, E., García-Vadillo, A., Espinosa, M., Macía-Villa, C., Morell-Hita, J. L., Martinez-Prada, C., Villaverde, V., Morado Quiroga, I., Guzón-Illescas, O., Barbadillo, C., Fernandez Prada, M., Godoy, H., Herranz Varela, A., Galindo Izquierdo, M., & Mazzucchelli, R. (2020). Orthopedic Surgery in Rheumatoid Arthritis: Results from the Spanish National Registry of Hospitalized Patients over 17 Years. The Journal of Rheumatology, 47(3), 341-348.

Yonemoto, Y., Okamura, K., Kaneko, T., Okura, C., Kobayashi, T., Suto, T., Tsushima, Y., & Takagishi, K. (2017). Effect of total knee arthroplasty on other joints in patients with rheumatoid arthritis evaluated by 18-FDG-PET. International Journal of Rheumatic Diseases, 20(6), 702-707.

Young, B. L., Watson, S. L., Perez, J. L., McGwin, G., Singh, J. A., & Ponce, B. A. (2018). Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis. The Journal of Rheumatology, 45(2), 158-164.

Asai, S., Kojima, T., Oguchi, T., Kaneko, A., Hirano, Y., Yabe, Y., Kanayama, Y., Takahashi, N., Funahashi, K., Hanabayashi, M., Hirabara, S., Yoshioka, Y., Takemoto, T., Terabe, K., Asai, N., & Ishiguro, N. (2015). Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan. Arthritis Care & Research, 67(10), 1363-1370.

Goodman, S. M., Bykerk, V. P., DiCarlo, E., Cummings, R. W., Donlin, L. T., Orange, D. E., Hoang, A., Mirza, S., McNamara, M., Andersen, K., Bartlett, S. J., Szymonifka, J., & Figgie, M. P. (2018). Flares in Patients with Rheumatoid Arthritis after Total Hip and Total Knee Arthroplasty: Rates, Characteristics, and Risk Factors. The Journal of Rheumatology, 45(5), 604-611.

Lee, Y. H., Ko, P. Y., Kao, S. L., Lin, M. C., & Cheng-Chung Wei, J. (2020). Risk of Total Knee and Hip Arthroplasty in Patients With Rheumatoid Arthritis: A 12-Year Retrospective Cohort Study of 65,898 Patients. The Journal of Arthroplasty, 35(12), 3517-3523.

Mooney, L., Lewis, P. L., Campbell, D. G., Peng, Y., & Hatton, A. (2019). Rates and outcomes of total knee replacement for rheumatoid arthritis compared to osteoarthritis. ANZ Journal of Surgery, 89(3), 184-190.

Rutherford, A. I., Subesinghe, S., Hyrich, K. L., & Galloway, J. B. (2018). Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 77(6), 905-910.

Cordtz, R. L., Zobbe, K., Højgaard, P., Kristensen, L. E., Overgaard, S., Odgaard, A., Lindegaard, H., & Dreyer, L. (2018). Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers. Annals of the Rheumatic Diseases, 77(2), 281-288.

Pitta, M., Esposito, C. I., Li, Z., Lee, Y. Y., Wright, T. M., & Padgett, D. E. (2018). Failure After Modern Total Knee Arthroplasty: A Prospective Study of 18,065 Knees. The Journal of Arthroplasty, 33(2), 407-414.

George, M. D., Baker, J. F., Winthrop, K., Alemao, E., Chen, L., Connolly, S., Hsu, J. Y., Simon, T. A., Wu, Q., Xie, F., Yang, S., & Curtis, J. R. (2019). Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study. Annals of Internal Medicine, 170(12), 825-836.

Goodman, S. M., Springer, B., Guyatt, G., Abdel, M. P., Dasa, V., George, M., Gewurz-Singer, O., Giles, J. T., Johnson, B., Lee, S., Mandl, L. A., Mont, M. A., Sculco, P., Sporer, S., Stryker, L., Turgunbaev, M., Brause, B., Chen, A. F., Gililland, J., Goodman, M., … Yates, A. (2017). 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Care & Research, 69(8), 1111-1124.

Borgas, Y., Gülfe, A., Kindt, M., & Stefánsdóttir, A. (2020). Anti-rheumatic treatment and prosthetic joint infection: an observational study in 494 elective hip and knee arthroplasties. BMC Musculoskeletal Disorders, 21(1), Article 410.

Salt, E., Wiggins, A. T., Rayens, M. K., Morris, B. J., Mannino, D., Hoellein, A., Donegan, R. P., & Crofford, L. J. (2017). Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis. Seminars in Arthritis and Rheumatism, 46(4), 423-429.



How to Cite

Herasymenko SI, Herasymenko АS, Huzhevskyi IV, Poluliakh MV, Babko AM. The effect of drug treatment on functional outcomes of hip and knee joint replacement in patients with rheumatoid arthritis . Zaporozhye Medical Journal [Internet]. 2021Apr.7 [cited 2024Jun.18];23(1):83-9. Available from:



Original research